4 min readOvercoming the challenges of low PD-L1 lung cancer: The latest immunotherapy regimenThe addition of immune checkpoint inhibitors to lung cancer treatment has shown promising outcomes in terms of increasing survival rates.
4 min readNeoadjuvant nivolumab plus chemotherapy: Examining the clinical trial that led to FDA approvalImmunotherapy is transforming cancer treatment. One such immunotherapy drug called, nivolumab has been approved by FDA for lung cancer.
